Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 2e-05 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.87 | 0.0003 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.17 | 0.0008 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.16 | 0.002 |